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The possibility that intracellular cyclic adenosine monophosphate concentration
([cAMP]i) may play a role in the action of CTL was suggested by the observation
that target cell lysis was inhibited when CTL were treated with either cholera toxin
(CT) or a cAMP analogue (1, 2). Recent data indicate that elevation of [cAMP]i
also blocks receptor-mediated T cell activation and the associated phosphorylation
of components of the TCR complex (3). In Jurkat cells, Imboden et al. (4) have
shown that cholera toxin inhibits TCR-mediated increases in intracellular calcium
concentration ([Ca2+]i), but that this inhibitory effect was not mimicked by other
treatments that raised [cAMP]i. More recently, Ledbetter et al. (5) showed that in-
creases in [Ca2+ ]i could also be inhibited by pertussis toxin (PT) treatment ofJurkat
cells. In the present study, the effects on murine CTL function ofCT, PT, and agents
that directly elevate [cAMP]i have been investigated in detail. In this system, both
CT and cAMP analogues inhibited conjugate formation and the receptor-stimulated
increase in [Ca2+]i, but had no effect on the expression of the TCR or other pro-
teins thought to be involved in target cell binding. PT treatment of these cells was
without effect on any measured parameter. These results suggest that cAMP may
be an important modulator of CTL function.
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Reagents.
￿
The binding (B) subunit of CT and the cAMP analogues, 8-bromoadenosine
3':5'-cyclic monophosphate (8Br-cAMP) and 6,2'-0-dibutyryladenosine 3':5'-cyclic monophos-
phate (dibutyryl-cAMP) were obtained from Sigma Chemical Co. (St. Louis, MO).
Cells.
￿
The characteristics and maintenance of the CTL clones and cell lines used here
have been previously described (6). A hamster hybridoma (145-2C11) that produces an mAb
that is specific for the e chain of T3 was generously provided by J . A. Bluestone (National
Cancer Institute, Bethesda, MD).
Measurement of(cAMP1,.
￿
CTL were incubated with the indicated concentrations CT (List
Biological Laboratories, Campbell, CA) for 1 h or PT (prepared as previously described,
reference 7) for 18 h. Cell pellets were extracted with 0.1 N HCl, and cAMP was determined
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using an automated radioimmunoassay that was performed by the University of'Virginia
Diabetes Center RIA Core Laboratory, Charlottesville, VA.
Flow Cytojluorimetric Determination of Conjugates and Cal'],.
￿
CTL were treated with CT or
8Br-cAMP for 1 h as described above and simultaneously with 5 4M indo-1/AM (8). Both
CTL and target cells were washed in a balanced salt solution (BSS) at pH 7.4, containing
140 mM NaCI, 5 mM KC1, 1 mM CaCl2, 1 MM MgCl2, 5 mM Hepes, 0.1% glucose, and
0.1% BSA, and were resuspended at 1 x 10' cells/ml. 100 ftl of the CTL suspension was
mixed with an equal volume of the target cell suspension, centrifuged for 2 min, and in-
cubated at 37°C for 10 min. The 400 nm/480 nm fluorescence-emission ratio from indo-l-
labeled CTL as determined on aflow cytofluorimeter (Epics V, CoulterElectronics Inc., Hia-
leah, Fl) was set to -0.5 on a scale of 0-1 by adjusting instrument settings. Underthese con-
ditions, target cells examined alone were outside of the range of the histogram. Conjugates
were defined as events falling >2 SD from the peak forward angle light scatter obtained from
the examination of CTL alone and were further restricted to those events falling above a
line drawn 2 SD below the peak fluorescence ratio of CTL alone. (9) Activated CTL were
defined as events falling>2 SD above the peak ratio fluorescence ofCTLs measured without
added targets. (9)
Determination of antibody-stimulated increases in [Caz` ]; was performed on a flow
cytofluorimeter using indo-l-labeled CTL essentially as previously described (5). The base-
line fluorescence emission ratiowas recorded for 30 sbefore protein-A-purified antiT3 mAb
at a final concentration of 50 !tg/ml was added to the sample. Data were acquired for 16 s
for each point with a total of 64 time points and 3-4 x 10' events for each determination.
Results
Three independent CTL clones exposed to cholera holotoxin, but not the non-
catalytic B subunit, showed a dose-dependent inhibition of specific target cell lysis
(Fig. 1 A) . In contrast, exposure to PT had no effect on cytotoxicity (Fig. 1 B). Prior
treatment of intact CTL with CT resulted in the modification of 92% of its 44-kD
substrate, while pertussis-toxin treatment resulted in the modification of 97 0 /c of its
38-kD substrate (datanot shown). Thus, theinability ofPT to inhibit CTL-mediated
cytotoxicity cannot be explained by lack of ADP-ribosylation of the toxin substrate.
CT treatment of CTL clones resulted in an increase in [cAMP]i, whereas PT
treatment did not (Table 1). Therefore, CT, but not PT, was able to modify a G
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FIGURE 1 . The CTL clones
III12-2 (O), 1D5 (A), and IH11
(p)were incubatedwith the in-
dicated concentrations of CT
(A)dibutryl cAMP (C), or 8Br-
cAMP (D) for 1 hor PT for18 h
(B). They were washed andin-
cubated in duplicate with SICr-
'
￿
labeledJY cellsat an E/T ratio
Dibutyryl-cAMP (mM)
￿
of 5:1. The cAMP analogues
p I
￿
were present throughout the
assay. (C)Thevalues shownare
forCTLtreatedfor 1 h with CT
Bsubunit at aconcentration of
10 vg/ml (A, open symbols) or left
untreated (A and B, closed
symbols). The spontaneous re-
lease of "Cr from target cells
wasnot altered by the presence
of any of the drugs.GRAY ET AL. BRIEF DEFINITIVE REPORT
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TABLE I
Effects of Bacterial Toxins on Intracellular Concentrations of
CAMP in Cytotoxic T Cells
[CAMP]; was determined by RIA using CTL clone III12-2 as described in
Materials and Methods . Values represent the mean of triplicate determinations,
and the numbers in parentheses represent pmol [cAMP];/106 cells.
protein with consequent activation of endogenous adenylate cyclase. Although CT
caused an increase in [cAMP]i, it was still possible that inhibition of cytotoxicity
was due to the action of the toxin on another regulatory G protein as has been previ-
ously hypothesized (4). However, treatment of CTL with cAMP analogues also in-
hibited of cytotoxicity (Fig. 1, C and D). These data suggest that CT may inhibit
CTL-mediated lysis through its ability to elevate [cAMP] ;.
Conjugate formation was determined by flow cytofluorimetery as an increase in
forward angle light scatter of CTL after binding to target cells (9). The reduction
in the proportion of CTL bound to JY cells ranged from 27-69 ° Io after 8Br-cAMP
treatment and from 70-85% after CT treatment. Both CT and 8Br-cAMP also re-
duced nonspecific conjugate formation with the irrelevant target cell Daudi by >72%.
Thus, at least one mechanism by which CT and [cAMP]i inhibit CTL-mediated
lysis is through a reduction in stable conjugate formation with target cells. The CTL
in these experiments were loaded with indo-1 in order to determine the proportion
of CTL that demonstrated an increase in [Ca2+]i after interaction with relevant
target cells (9). As shown in Table II, 8Br-cAMP reduced the proportion of acti-
vated CTL by 68%, which was a significantly greater decrease than that produced
in conjugate formation (p < 0.01). CT inhibited activation by >75% as compared
with untreated CTL (Table 11) . The proportion of CTL that was counted as acti-
vated by incubation with Daudi cells was low in all samples and confirms earlier
findings (9).
Although conjugate formation was inhibited by CT and Or-cAMP, treatment
of CTL with either CT or 8Br-cAMP did not affect the level of expression of TCR,
T3, LFA-1, or Lyt-2 as determined by mAb binding (data not shown). Therefore,
the effect of CT and 8Br-cAMP on increases in [Ca2+]; induced by antiTCR mAbs
was investigated. Addition of antiT3 mAb resulted in an increase in [Ca2, ]i, evi-
dent as an increased fluorescence ratio (Fig. 2 A) . This increase was eliminated by
prior treatment of CTL with either CT (Fig. 2 B) or 8Br-cAMP (Fig. 2 C). Since
the target cell binding defect was bypassed using mAbs, these data indicate that an-
other separate mechanism by which elevated [cAMP]i inhibits CTL-mediated cy-
totoxicity is likely to involve inhibition ofthe receptor-stimulated increase in [Ca2+ ]; .
Treatment Picomoles cAMP/milligram protein
Control 8 (1)
CT (ug/rnl)
10 86 (12)
1 93 (13)
0.1 84 (11)
0.01 81 (11)
0.001 34 (5)
0 8 (1)
1'T
10 ug/ml 9 (1)1966
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TABLE II
Inhibition of Conjugate Formation and CTL Activation by Elevated Intracellular CAMP Concentration
CTL were examined by flow cytofluorimetry as described in Materials and Methods . When tested alone,
the percentage ofboth treated and untreated CTL within the window defined for conjugation had a mean
value for the three experiments of 6 .1% and was 2.5% for activation . The value obtained for a particular
experiment was subtracted from the data presented in the table . A total of 30,000 events were obtained
for each determination .
* Not tested .
Discussion
CT or 8Br-cAMP treatment abolished the increase in [Ca2* ] ; that normally
results from binding of antiT3 mAb and significantly reduced the increase stimu-
lated by relevant cellular antigen . These results stand in contrast to those reported
by Imboden et al . (4), who showed that CT, but not forskolin or cAMP analogs,
FIGURE 2 .
￿
CTL clone III12-2
was labeled with indo-i and
concurrently incubated with
medium (A), 1 hg/ml CT (B),
or 10 mM 8Br-cAMP (C) for 1
h . AntiT3 mAb (50 gg/ml) was
added at times indicated by the
arrows . The scalloping, which
is evident along the x-axis, is an
artifact of the computer pro-
gram used to generate the
graphs .
Target cell
Exp .
Conjugation
1
Activation
Exp .
Conjugation
2
Activation
Exp .
Conjugation
3
Activation
JY
CTR 43.0 48 .0 47 .0 39 .7 40 .9 46 .2
8Br 13 .3 6 .5 34 .2 10 .3 18 .8 26 .7
CT 6 .5 9 .7 14 .2 11 .2 NT* NT
Daudi
CTR 20 .9 11 .1 14 .6 2 .6 14 .2 9 .3
8Br 8 .5 10 .1 5 .3 1 .8 0 .9 2 .0
CT 8 .1 6 .3 5 .7 3 .2 NT NTGRAY ET AL. BRIEF DEFINITIVE REPORT
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abolished the increase in [Cal' ]; induced in Jurkat cells by antiT3 antibodies. The
disparity in the effects of CAMP analogs in these two studies may reflect differences
between Jurkat and cloned CTLs. It is also possible that CT does modify a G pro-
tein, distinct from Gs, that is a participant in signal transduction in CTL. However,
if this is the case, then the effect of CT on this putative G protein must be masked
in CTL by the actions ofelevated [CAMP]i alone. In this regard, CT appeared more
effective in inhibiting the interaction of CTL with target cells than was 8Br-cAMP.
There are similarities between the actions ofcAMP reported here and those reported
to occur in platelets and T cells by other groups. In platelets, elevated [cAMP]i
eliminates receptor-stimulated increases in [Cal' ]; by inhibiting Call influx (10),
mobilization (10), and, possibly, sequestration (11). Furthermore, it has been shown
that treatment ofJurkat cells with a cAMP analogue inhibits the antigen-induced
production ofinositol polyphosphates that have been implicated in control of Cat+
influx and mobilization (3). Taken together, these results are in accord with the idea
that CT acts at least partially through elevation of [cAMP]i to inhibit antigen-
induced increases in [Ca2, ]i by its effects on inositol polyphosphate production.
Elevated [cAMP]; also results in a marked decrease in the ability of CTL to bind
to either relevant or irrelevant target cells. This is not due to a decrease in the ex-
pression ofthe membrane proteins currently thought to be responsible for initiation
or maintenance of the CTL-target cell interaction. However, cAMP-dependent pro-
tein phosphorylation has been shown to reduce receptor affinity in some systems
(12), and it is possible that a similar phenomenon is occurring in T lymphocytes.
LFA-1 has been shown to play a key role in conjugate formation (13). Because elevated
[cAMP]i inhibited conjugate formation with both relevant and irrelevant targets,
it is tempting to speculate that one mechanism of action of cAMP may involve this
protein.
The relationship between cAMP-mediated inhibition of the antigen-stimulated
increase in [Ca2,
]i and the inhibition mediated by membrane hyperpolarization (8)
is not clear and will require further investigation. However, the present study has
provided evidence for at least two independent sites of inhibitory action by elevated
[cAMP]; on cytotoxic T lymphocyte function. Because of its effects, an attractive
hypothesis is that an increase in [cAMP]; serves to terminate the lytic interaction
by ending CTL-target cell adhesion as well as the increase in [Cal , ] ;, which are
both required for lytic function. Regardless of the actual mechanism, these results
provide suggestive evidence concerning the mechanisms by which CTL activity may
be regulated.
Summary
Cholera toxin (CT), but not pertussis toxin (PT), treatment ofcloned murine CTL
inhibited target cell lysis in a dose-dependent fashion. The effects of CT were mim-
icked by forskolin and cyclic adenosine monophosphate (cAMP) analogues. Inhibi-
tion of cytotoxicity by CT and cAMP analogs was mediated in part by attenuation
of conjugate formation. Additionally, both CT and cAMP analogs blocked the in-
crease in intracellular Ca
ll
induced by stimulation of the TCR complex by mAbs.
These findings indicate that cAMP inhibits the activity ofCTL by two distinct mech-
anisms and suggests a role for this second messenger in CTL-mediated cytolysis.1968
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